Cargando…

Identification of the molecular mechanism and candidate markers for diabetic nephropathy

BACKGROUND: Diabetic nephropathy (DN) is one of the most common complications in diabetic patients. New strategies are needed to delay the occurrence and development of this pathology. METHODS: Differentially expressed genes (DEGs) in glomeruli and renal tubules were identified using the GSE30122 da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chun, Liu, Liping, Luo, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761143/ https://www.ncbi.nlm.nih.gov/pubmed/36544633 http://dx.doi.org/10.21037/atm-22-5128

Ejemplares similares

The Molecular Mechanism of Rhein in Diabetic Nephropathy
por: Zeng, Cong-Cong, et al.
Publicado: (2014)

Identification of an miRNA Regulatory Network and Candidate Markers for Ischemic Stroke Related to Diabetes
por: Zhou, Hui, et al.
Publicado: (2021)

Identification of Genes Reveals the Mechanism of Cell Ferroptosis in Diabetic Nephropathy
por: Wang, Xian, et al.
Publicado: (2022)

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues
por: Oltean, Sebastian, et al.
Publicado: (2017)

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets
por: Zoja, Carlamaria, et al.
Publicado: (2020)

Identification of Dysregulated Mechanisms and Candidate Gene Markers in Chronic Obstructive Pulmonary Disease
por: Lin, Jie, et al.
Publicado: (2022)

Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
por: Hu, Yaling, et al.
Publicado: (2022)

An Overview of the Posttranslational Modifications and Related Molecular Mechanisms in Diabetic Nephropathy
por: Cao, Yu, et al.
Publicado: (2021)

Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients
por: Overgaard, Anne Julie, et al.
Publicado: (2010)

Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile
por: Chen, Zhi, et al.
Publicado: (2016)

The unique molecular mechanism of diabetic nephropathy: a bioinformatics analysis of over 250 microarray datasets
por: Zhou, Le-Ting, et al.
Publicado: (2021)

Molecular mechanism of smurf2 in regulating the expression of SnoN in diabetic nephropathy
por: Xu, Zhuojia, et al.
Publicado: (2017)

Tryptophan as a surrogate prognostic marker for diabetic nephropathy
por: Chou, Chien‐An, et al.
Publicado: (2017)

Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes
por: Moosaie, Fatemeh, et al.
Publicado: (2022)

Identification of Periostin as a Critical Marker of Progression/Reversal of Hypertensive Nephropathy
por: Guerrot, Dominique, et al.
Publicado: (2012)

Urinary Markers of Glomerular Injury in Diabetic Nephropathy
por: Cohen-Bucay, Abraham, et al.
Publicado: (2012)

Candidate gene and mechanism investigations in congenital obstructive nephropathy based on bioinformatics analysis
por: Xin, Guangda, et al.
Publicado: (2018)

An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy
por: Bai, Zhenyu, et al.
Publicado: (2022)

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy
por: Kim, So Young, et al.
Publicado: (2018)

Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy
por: Ming, Jie, et al.
Publicado: (2022)

Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
por: Paulini, Janaina, et al.
Publicado: (2016)

Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning
por: Xu, Mingming, et al.
Publicado: (2023)

The Eutopic Endometrium Proteome in Endometriosis Reveals Candidate Markers and Molecular Mechanisms of Physiopathology
por: Méar, Loren, et al.
Publicado: (2022)

Identification of Potential Molecular Mechanisms and Candidate Genes Involved in The Acute Phase of Myocardial Infarction
por: Yang, Yushuang, et al.
Publicado: (2018)

Common gene signatures and molecular mechanisms of diabetic nephropathy and metabolic syndrome
por: Zhang, Chengyu, et al.
Publicado: (2023)

Mechanism of hypertension in diabetic nephropathy
por: Nazar, Chaudhary Muhammad Junaid
Publicado: (2014)

Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes
por: Khandare, Sagar Ashokrao, et al.
Publicado: (2017)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Urinary Markers of Tubular Injury in Early Diabetic Nephropathy
por: Fiseha, Temesgen, et al.
Publicado: (2016)

ANGPTL4: A Predictive Marker for Diabetic Nephropathy
por: Al Shawaf, Eman, et al.
Publicado: (2019)

Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods
por: WANG, WAN-NING, et al.
Publicado: (2016)

Identification of potential gene markers in gestational diabetes mellitus
por: Tang, Weichun, et al.
Publicado: (2022)

Candidal Prevalence in Diabetics and its Species Identification
por: Chouhan, Shweta, et al.
Publicado: (2019)

Exploring the Molecular Mechanism of Liuwei Dihuang Pills for Treating Diabetic Nephropathy by Combined Network Pharmacology and Molecular Docking
por: Wang, Gaoxiang, et al.
Publicado: (2021)

FABP1 and FABP2 as markers of diabetic nephropathy
por: Tsai, I-Ting, et al.
Publicado: (2020)

MicroRNA-21 as an Early Marker of Nephropathy in Patients with Type 1 Diabetes
por: Fouad, Mohamed, et al.
Publicado: (2020)

Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring
por: Wang, Xi-De, et al.
Publicado: (2007)

LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy
por: Zhang, Di, et al.
Publicado: (2022)

Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
por: Wang, Lin, et al.
Publicado: (2021)

Diabetic nephropathy in mice is aggravated by the absence of podocyte IRE1 and is correlated with reduced kidney ADH1 expression
por: Xie, Liping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4kn3g5dealrcksgb9me7qfdfh